Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 7, 2019

View Archived Issues

Loss of function of ADAR1 in tumor cells as a new strategy to overcome immunotherapy resistance

Nanoscavenger versus neurotoxins

Chemotherapy can facilitate metastases

Mavupharma names its first immuno-oncology clinical development candidate

AbbVie and Tizona Therapeutics to jointly develop CD-39-targeted therapeutics

NLRC5, a new diagnostic marker of IgA nephritis and its progression

Bionomics initiates phase II MODULATE study of BNC-105 in combination with nivolumab

Lundbeck initiates phase II study of Lu-AF-11167 for the treatment of schizophrenia

Obesity may be linked to anxiety via senescence

Pse-T2 shows promising activity in a mouse wound model infected with MDR strains

Positive topline results presented from first cohort of phase I/II study of DTX-401

CHDI-390576, a novel CNS-penetrant benzhydryl hydroxamic acid class IIa HDAC inhibitor

Phase I results reported for oral ferroportin inhibitor VIT-2763

Gilead and Yuhan enter licensing and collaboration agreement to treat NASH-related fibrosis

PRKCD targeting found useful against EGFR inhibitor-resistant lung cancer

Galapagos initiates phase I trial with GLPG-3312

Valneva announces promising phase I interim data on Chikungunya vaccine candidate VLA-1553

Galapagos initiates phase IIa study of GLPG-1690 in systemic sclerosis

Jazz and Codiak collaborate on exosome therapeutics to treat cancer

FDA clears IND for phase I trial of ARV-110 in metastatic castration-resistant prostate cancer

Adaptive Biotechnologies and Genentech collaborate on neoantigen-directed T-cell cancer therapies

Regulus reports preliminary interim data from mouse chronic toxicity study of RGLS-4326

KCI-807 compound discovered as an androgen receptor function disruptor in prostate cancer

Idorsia begins multiple-dose study of cenerimod for SLE

Sojournix completes financing to advance SJX-653 for menopausal vasomotor symptoms

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...